Tideglusib,一种有前景的壬苯醇醚-9避孕药替代品

Q2 Medicine Contraception: X Pub Date : 2019-01-01 DOI:10.1016/j.conx.2019.100007
Zhiting Chen , Niyan Shu , Yuzhu Wang , Yiting Yang , Zhiyu Shao , Fang Tian , Minjie Xia , Zhikai Wang , Xin Wang , Xing Feng , Xianliang Huang , Weihua Li , Heguo Yu , Hua Diao
{"title":"Tideglusib,一种有前景的壬苯醇醚-9避孕药替代品","authors":"Zhiting Chen ,&nbsp;Niyan Shu ,&nbsp;Yuzhu Wang ,&nbsp;Yiting Yang ,&nbsp;Zhiyu Shao ,&nbsp;Fang Tian ,&nbsp;Minjie Xia ,&nbsp;Zhikai Wang ,&nbsp;Xin Wang ,&nbsp;Xing Feng ,&nbsp;Xianliang Huang ,&nbsp;Weihua Li ,&nbsp;Heguo Yu ,&nbsp;Hua Diao","doi":"10.1016/j.conx.2019.100007","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>We aimed to evaluate the antifertility activity and vaginal irritation effects of tideglusib in vivo using rabbit models and to evaluate the cytotoxical effects of tideglusib to sperm, vaginal cells and vaginal bacteria (<em>L. acidophilus</em>) in vitro.</p></div><div><h3>Study design</h3><p>We treated female rabbits with vaginal tideglusib 1 mM, nonoxynol-9 (N-9) or vehicle control (Poloxamer 407). In experiment 1, we sacrificed females (<em>n</em> = 6 each) after 10 days of daily administration and assessed vaginal histological changes using Eckstein irritation score. In experiment 2, females (<em>n</em> = 9 each) received estradiol benzoate to induce ovulation 24 h prior to vaginal treatment followed by introduction of a fertile male. These females underwent necropsy at the 21st day to assess pregnancy status. In experiment 3, we used an HTM-TOX IVOS sperm motility analyzer and scanning electron microscopy (SEM) to evaluate the effect of tideglusib on human sperm samples. In experiment 4, we evaluated the effect of tideglusib on lactobacillus and vaginal cell growth in vitro.</p></div><div><h3>Results</h3><p>The total irritation score of tideglusib vs. N-9 was 3.4 ± 2.07 vs. 7.8 ± 3.82, p<!--> <!-->&lt;.05. The pregnancy rate of tideglusib, N-9 and control group was 11.1%, 0% and 88.9%, respectively. Tideglusib exhibited a dose-dependent spermostatic/spermicidal activity, and the minimum effective concentrations of tideglusib and N-9 were 8.724 ± 3.047 μM and 219.75 ± 41.78 μM, respectively. SEM and transmission electron microscopy revealed acrosomal membrane impairments caused by tideglusib. Tideglusib was much less toxic to vaginal cells and <em>L. acidophilus</em> than N-9 in vitro.</p></div><div><h3>Conclusions</h3><p>Evaluation using rabbit models indicated that tideglusib is a prospective spermicidal contraceptive with low vaginal irritation effects.</p></div><div><h3>Implications</h3><p>Tideglusib or tideglusib analogues may be a contraceptive with perspective to replace N-9. It is possible for a spermicide to balance spermicidal activity and vaginal/cervical irritation effects very well.</p></div>","PeriodicalId":10655,"journal":{"name":"Contraception: X","volume":"1 ","pages":"Article 100007"},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.conx.2019.100007","citationCount":"3","resultStr":"{\"title\":\"Tideglusib, a prospective alternative to nonoxynol-9 contraceptive\",\"authors\":\"Zhiting Chen ,&nbsp;Niyan Shu ,&nbsp;Yuzhu Wang ,&nbsp;Yiting Yang ,&nbsp;Zhiyu Shao ,&nbsp;Fang Tian ,&nbsp;Minjie Xia ,&nbsp;Zhikai Wang ,&nbsp;Xin Wang ,&nbsp;Xing Feng ,&nbsp;Xianliang Huang ,&nbsp;Weihua Li ,&nbsp;Heguo Yu ,&nbsp;Hua Diao\",\"doi\":\"10.1016/j.conx.2019.100007\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><p>We aimed to evaluate the antifertility activity and vaginal irritation effects of tideglusib in vivo using rabbit models and to evaluate the cytotoxical effects of tideglusib to sperm, vaginal cells and vaginal bacteria (<em>L. acidophilus</em>) in vitro.</p></div><div><h3>Study design</h3><p>We treated female rabbits with vaginal tideglusib 1 mM, nonoxynol-9 (N-9) or vehicle control (Poloxamer 407). In experiment 1, we sacrificed females (<em>n</em> = 6 each) after 10 days of daily administration and assessed vaginal histological changes using Eckstein irritation score. In experiment 2, females (<em>n</em> = 9 each) received estradiol benzoate to induce ovulation 24 h prior to vaginal treatment followed by introduction of a fertile male. These females underwent necropsy at the 21st day to assess pregnancy status. In experiment 3, we used an HTM-TOX IVOS sperm motility analyzer and scanning electron microscopy (SEM) to evaluate the effect of tideglusib on human sperm samples. In experiment 4, we evaluated the effect of tideglusib on lactobacillus and vaginal cell growth in vitro.</p></div><div><h3>Results</h3><p>The total irritation score of tideglusib vs. N-9 was 3.4 ± 2.07 vs. 7.8 ± 3.82, p<!--> <!-->&lt;.05. The pregnancy rate of tideglusib, N-9 and control group was 11.1%, 0% and 88.9%, respectively. Tideglusib exhibited a dose-dependent spermostatic/spermicidal activity, and the minimum effective concentrations of tideglusib and N-9 were 8.724 ± 3.047 μM and 219.75 ± 41.78 μM, respectively. SEM and transmission electron microscopy revealed acrosomal membrane impairments caused by tideglusib. Tideglusib was much less toxic to vaginal cells and <em>L. acidophilus</em> than N-9 in vitro.</p></div><div><h3>Conclusions</h3><p>Evaluation using rabbit models indicated that tideglusib is a prospective spermicidal contraceptive with low vaginal irritation effects.</p></div><div><h3>Implications</h3><p>Tideglusib or tideglusib analogues may be a contraceptive with perspective to replace N-9. It is possible for a spermicide to balance spermicidal activity and vaginal/cervical irritation effects very well.</p></div>\",\"PeriodicalId\":10655,\"journal\":{\"name\":\"Contraception: X\",\"volume\":\"1 \",\"pages\":\"Article 100007\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.conx.2019.100007\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Contraception: X\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2590151619300061\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contraception: X","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590151619300061","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 3

摘要

目的利用家兔模型,研究藻绿素的抗生育活性和阴道刺激作用,并在体外研究藻绿素对精子、阴道细胞和阴道细菌(嗜酸乳杆菌)的细胞毒作用。研究设计我们用阴道tideglusib 1 mM、壬氧醇-9 (N-9)或对照物(poloxam407)治疗雌性家兔。在实验1中,我们在每天给药10 天后处死女性(n = 6人),并使用Eckstein刺激评分评估阴道组织学变化。在实验2中,雌性(n = 各9只)在阴道治疗前24 小时接受苯甲酸雌二醇诱导排卵,然后引入有生育能力的雄性。这些雌性在第21天进行尸检以评估妊娠状况。在实验3中,我们使用HTM-TOX IVOS精子活力分析仪和扫描电镜(SEM)来评估tideglusib对人类精子样本的影响。在实验4中,我们评估了tideglusib对体外乳酸菌和阴道细胞生长的影响。结果tideglusib与N-9的总刺激评分分别为3.4 ± 2.07 vs. 7.8 ± 3.82,p < 0.05。替地格鲁菌组、N-9组和对照组的妊娠率分别为11.1%、0%和88.9%。Tideglusib和N-9的最小有效浓度分别为8.724 ± 3.047 μM和219.75 ± 41.78 μM。扫描电镜和透射电子显微镜显示顶体膜损伤引起的潮汐glusib。Tideglusib对阴道细胞和嗜酸乳杆菌的毒性远低于N-9。结论对家兔模型的评价表明,甲氨苄是一种有前景的杀精避孕药,对阴道刺激作用小。意义替格卢昔或替格卢昔类似物可能是一种有希望取代N-9的避孕药。杀精剂可以很好地平衡杀精活性和阴道/宫颈刺激效应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

摘要图片

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Tideglusib, a prospective alternative to nonoxynol-9 contraceptive

Objectives

We aimed to evaluate the antifertility activity and vaginal irritation effects of tideglusib in vivo using rabbit models and to evaluate the cytotoxical effects of tideglusib to sperm, vaginal cells and vaginal bacteria (L. acidophilus) in vitro.

Study design

We treated female rabbits with vaginal tideglusib 1 mM, nonoxynol-9 (N-9) or vehicle control (Poloxamer 407). In experiment 1, we sacrificed females (n = 6 each) after 10 days of daily administration and assessed vaginal histological changes using Eckstein irritation score. In experiment 2, females (n = 9 each) received estradiol benzoate to induce ovulation 24 h prior to vaginal treatment followed by introduction of a fertile male. These females underwent necropsy at the 21st day to assess pregnancy status. In experiment 3, we used an HTM-TOX IVOS sperm motility analyzer and scanning electron microscopy (SEM) to evaluate the effect of tideglusib on human sperm samples. In experiment 4, we evaluated the effect of tideglusib on lactobacillus and vaginal cell growth in vitro.

Results

The total irritation score of tideglusib vs. N-9 was 3.4 ± 2.07 vs. 7.8 ± 3.82, p <.05. The pregnancy rate of tideglusib, N-9 and control group was 11.1%, 0% and 88.9%, respectively. Tideglusib exhibited a dose-dependent spermostatic/spermicidal activity, and the minimum effective concentrations of tideglusib and N-9 were 8.724 ± 3.047 μM and 219.75 ± 41.78 μM, respectively. SEM and transmission electron microscopy revealed acrosomal membrane impairments caused by tideglusib. Tideglusib was much less toxic to vaginal cells and L. acidophilus than N-9 in vitro.

Conclusions

Evaluation using rabbit models indicated that tideglusib is a prospective spermicidal contraceptive with low vaginal irritation effects.

Implications

Tideglusib or tideglusib analogues may be a contraceptive with perspective to replace N-9. It is possible for a spermicide to balance spermicidal activity and vaginal/cervical irritation effects very well.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Contraception: X
Contraception: X Medicine-Obstetrics and Gynecology
CiteScore
5.10
自引率
0.00%
发文量
17
审稿时长
22 weeks
期刊最新文献
Outpatient medical management of later second trimester abortion (18–23.6 weeks) with procedural evacuation backup: A large case series Experiences of delay-causing obstacles and mental health at the time of abortion seeking Maximizing the effectiveness of 1.5 mg levonorgestrel for emergency contraception: The case for precoital use How does person-centered maternity care relate to postpartum contraceptive counseling and use? Evidence from a longitudinal study of women delivering at health facilities in Ethiopia Dilation and evacuation versus medication abortion at 15–24 weeks of gestation in low-middle income country: A retrospective cohort study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1